Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Eggimann Anne-Virginie, Directeur Réglementaire. Insider active across 1 company, notably bluebird bio, Inc.. Aggregated, 2 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €7k. History available since 1 February 2022. The latest transaction was filed on 12 July 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Anne-Virginie Eggimann is the Chief Regulatory Officer at bluebird bio, Inc. She oversees the company's regulatory activities, ensuring that all products and services comply with legal standards and requirements. Anne-Virginie's role is essential in developing strategies to navigate the complex regulatory landscape of the biopharmaceutical industry. Her expertise in compliance and regulation is crucial for the success of bluebird bio, Inc.